# A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

> **NCT07275242** · PHASE1 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 107 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** SHR-A1811 Subcutaneous Injection
- **DRUG:** SHR-A1811 for Injection

## Key facts

- **NCT ID:** NCT07275242
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-23
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 107 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07275242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07275242, "A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07275242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*